Cytogenetic characteristics of and prognosis for acute myeloid leukemia in 107 children.

acute childhood leukemias cytogenetic analysis karyotype leukemia myeloid prognosis

Journal

Asian biomedicine : research, reviews and news
ISSN: 1875-855X
Titre abrégé: Asian Biomed (Res Rev News)
Pays: Thailand
ID NLM: 101465147

Informations de publication

Date de publication:
Apr 2021
Historique:
medline: 30 4 2021
pubmed: 30 4 2021
entrez: 8 8 2023
Statut: epublish

Résumé

Patients diagnosed with acute myeloid leukemia (AML) in childhood have a poor prognosis. A better understanding of prognostic factors will assist patients and clinicians in making difficult treatment decisions. To understand further the cytogenetic characteristics of and reassess the prognostic value of cytogenetic abnormalities in childhood AML. Conventional karyotypes of 107 children with AML were analyzed retrospectively. The cases were divided into 4 groups based on genetic rearrangements; namely patients with: t(15;17)/ All French-American-British (FAB) subtypes of AML were detected in 107 patients. We successfully cultured 81 of 107 bone marrow specimens, of which 60 cases had abnormal karyotypes. The most common abnormal karyotypes were t(8;21) (17/81 cases), followed by t(15;17) (13/81 cases), -X/Y (10/81 cases). There were no significant differences ( Chromosomal abnormalities may provide important prognostic factors for AML in children and be helpful for risk stratification and individual treatment.

Sections du résumé

Background UNASSIGNED
Patients diagnosed with acute myeloid leukemia (AML) in childhood have a poor prognosis. A better understanding of prognostic factors will assist patients and clinicians in making difficult treatment decisions.
Objectives UNASSIGNED
To understand further the cytogenetic characteristics of and reassess the prognostic value of cytogenetic abnormalities in childhood AML.
Methods UNASSIGNED
Conventional karyotypes of 107 children with AML were analyzed retrospectively. The cases were divided into 4 groups based on genetic rearrangements; namely patients with: t(15;17)/
Results UNASSIGNED
All French-American-British (FAB) subtypes of AML were detected in 107 patients. We successfully cultured 81 of 107 bone marrow specimens, of which 60 cases had abnormal karyotypes. The most common abnormal karyotypes were t(8;21) (17/81 cases), followed by t(15;17) (13/81 cases), -X/Y (10/81 cases). There were no significant differences (
Conclusions UNASSIGNED
Chromosomal abnormalities may provide important prognostic factors for AML in children and be helpful for risk stratification and individual treatment.

Identifiants

pubmed: 37551405
doi: 10.2478/abm-2021-0010
pii: abm-2021-0010
pmc: PMC10388776
doi:

Types de publication

Journal Article

Langues

eng

Pagination

79-89

Informations de copyright

© 2021 Wanzi Chen et al., published by Sciendo.

Références

Leuk Lymphoma. 2018 Oct;59(10):2273-2286
pubmed: 29164965
Blood. 2012 Jun 21;119(25):5980-8
pubmed: 22566607
Blood. 2005 Jul 15;106(2):447-53
pubmed: 15677559
Leukemia. 2019 Aug;33(8):1934-1943
pubmed: 30760869
Blood. 2012 Oct 18;120(16):3187-205
pubmed: 22879540
Asian Pac J Cancer Prev. 2010;11(5):1393-5
pubmed: 21198299
J Clin Oncol. 2010 Jun 1;28(16):2674-81
pubmed: 20439644
Blood. 2017 Jun 8;129(23):3051-3058
pubmed: 28411282
Ups J Med Sci. 2018 Mar;123(1):19-27
pubmed: 29493383
Genes Chromosomes Cancer. 2014 Aug;53(8):667-75
pubmed: 24753324
Expert Rev Anticancer Ther. 2018 Mar;18(3):277-293
pubmed: 29338495
Clin Lymphoma Myeloma Leuk. 2018 Dec;18(12):773-780
pubmed: 30340992
Cancer Genet. 2011 Aug;204(8):430-8
pubmed: 21962893
Zhonghua Xue Ye Xue Za Zhi. 2012 Sep;33(9):725-8
pubmed: 23336225
J Pediatr Hematol Oncol. 2018 Oct;40(7):541-547
pubmed: 29794644
Leukemia. 2014 Jul;28(7):1449-58
pubmed: 24402164
Int J Lab Hematol. 2019 Aug;41(4):485-492
pubmed: 31099482
Br J Cancer. 2015 Jan 20;112(2):251-9
pubmed: 25562432
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2004 Oct;21(5):512-4
pubmed: 15476184
Pediatr Hematol Oncol. 2011 May;28(4):269-78
pubmed: 21345081
Nucleic Acids Res. 2018 Nov 30;46(21):11214-11228
pubmed: 30500954
Eur J Pediatr. 2017 Oct;176(10):1329-1337
pubmed: 28812191
Blood. 2013 Jul 11;122(2):170-8
pubmed: 23673857
Mol Biol Rep. 2015 Feb;42(2):451-6
pubmed: 25287662
J Natl Compr Canc Netw. 2017 Jul;15(7):926-957
pubmed: 28687581
Zhonghua Xue Ye Xue Za Zhi. 2018 Jan 14;39(1):9-14
pubmed: 29551026
Pediatr Int. 2018 Jan;60(1):47-51
pubmed: 29105243
Eur J Haematol. 2007 Jun;78(6):468-76
pubmed: 17419750
Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):37-44
pubmed: 29222235
Ann Hematol. 2019 Jan;98(1):83-91
pubmed: 30251205
Neoplasma. 2015;62(6):864-71
pubmed: 26458322
Ann Hematol. 2019 Jun;98(6):1403-1411
pubmed: 30915498

Auteurs

Wanzi Chen (W)

Department of Hematology, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, China.

Jinghui Yang (J)

Fujian Provincial Key Laboratory on Hematology, Fujian Institute of Hematology, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, China.

Ping Chen (P)

Department of Pediatric Hematology, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, China.

Classifications MeSH